Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Operating Expenses (2016 - 2025)

Wave Life Sciences' Operating Expenses history spans 11 years, with the latest figure at $73.7 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 21.27% year-over-year to $73.7 million; the TTM value through Dec 2025 reached $258.1 million, up 18.02%, while the annual FY2025 figure was $258.1 million, 18.02% up from the prior year.
  • Operating Expenses reached $73.7 million in Q4 2025 per WVE's latest filing, up from $64.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $73.7 million in Q4 2025 to a low of $37.9 million in Q4 2021.
  • Average Operating Expenses over 5 years is $49.6 million, with a median of $45.2 million recorded in 2022.
  • Peak YoY movement for Operating Expenses: dropped 19.73% in 2021, then increased 27.32% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $37.9 million in 2021, then grew by 18.29% to $44.8 million in 2022, then grew by 6.55% to $47.7 million in 2023, then rose by 27.32% to $60.8 million in 2024, then rose by 21.27% to $73.7 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Operating Expenses are $73.7 million (Q4 2025), $64.0 million (Q3 2025), and $61.5 million (Q2 2025).